Myricx Bio
Biotechnology company developing next-generation antibody-drug conjugates (ADCs) for cancer therapy, using innovative linker-payload technologies to improve efficacy and safety.
Website
https://www.myricx.comLocation
London, United Kingdom
Founded
2019
Investors
2
Categories
therapeutics, biotech, oncology, adc, antibody-drug-conjugates
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Novo Holdings | Hellerup, Denmark | biotech-focused | seedseries-a+3 | 13 |
| Abingworth | London, UK / Boston, USA | biotech-focused | seedseries-a+3 | 34 |